Serra-Prat, M.; BolÃbar, I.; Palomera, E.; Lavado, À.; Almirall, J.
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Preventing Community-Acquired Pneumonia in Adults: A Population-Based Cohort Study. Vaccines 2024, 12, 1023.
https://doi.org/10.3390/vaccines12091023
AMA Style
Serra-Prat M, BolÃbar I, Palomera E, Lavado À, Almirall J.
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Preventing Community-Acquired Pneumonia in Adults: A Population-Based Cohort Study. Vaccines. 2024; 12(9):1023.
https://doi.org/10.3390/vaccines12091023
Chicago/Turabian Style
Serra-Prat, Mateu, Ignasi BolÃbar, Elisabet Palomera, Àngel Lavado, and Jordi Almirall.
2024. "Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Preventing Community-Acquired Pneumonia in Adults: A Population-Based Cohort Study" Vaccines 12, no. 9: 1023.
https://doi.org/10.3390/vaccines12091023
APA Style
Serra-Prat, M., BolÃbar, I., Palomera, E., Lavado, À., & Almirall, J.
(2024). Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Preventing Community-Acquired Pneumonia in Adults: A Population-Based Cohort Study. Vaccines, 12(9), 1023.
https://doi.org/10.3390/vaccines12091023